New Delhi: HL August 14, 2026
The procurement of medicines, surgical supplies, linen and medical equipment worth around Rs. 650 crore in Delhi’s health department has come under scrutiny, with questions being raised over documentation, quality testing and transparency in the purchasing process.
According to a media report, documents relating to purchases made through the Central Procurement Agency (CPA), including bills and quality-testing reports, were reportedly not available in some cases. The issue has raised questions about whether adequate records were maintained at every stage of the procurement process.
Health Minister Dr. Pankaj Singh had earlier maintained that medicines and other medical supplies were procured according to prescribed rules. However, email correspondence cited in the report has reportedly brought renewed attention to the availability of procurement and quality-control records.
Email Raises Questions Over Procurement Records
According to the report, an email sent on August 11 from the DGHS office to medical superintendents of Delhi government hospitals sought information concerning medicines, surgical materials and other medical supplies available in hospital stores.
The communication reportedly referred to the absence of important original documents, including supply orders, supply challans, bills, e-way bills, approved samples and quality-testing reports.
The email also reportedly mentioned preparing inventory on the basis of physical verification conducted under the supervision of a committee and issuing necessary directions for the timely distribution of available materials.
The availability of such records is particularly important in large-scale government procurement because they provide a trail from purchase orders and supply to quality verification, stock entry and payment.
Quality Testing Becomes a Key Issue
The report also highlights questions surrounding the quality-testing process for medicines purchased through the CPA.
According to officials cited in the report, hospitals previously sent their requirements to the CPA, after which supply orders were issued to pharmaceutical manufacturers through the tendering process.
Medicines were reportedly subjected to quality checks at government or NABL-accredited laboratories before being cleared for use. Such testing is intended to verify whether medicines contain the required quantity of active pharmaceutical ingredients (API) and meet prescribed quality standards.
The reported absence or non-availability of quality-testing records has therefore raised questions about how the quality and authenticity of certain supplies were verified before reaching patients.
Purchases Also Made by Other Institutions
The report further states that some of the medicines procured in Delhi were also purchased by institutions such as the Railways, AIIMS and health institutions in other states.
However, questions surrounding the availability of Delhi’s procurement records have intensified the debate over documentation and transparency.
The report also refers to concerns regarding certain medicines and medical equipment, although such claims would require verification through official records and independent investigation.
Centralised Procurement System Under Focus
The report says the health department moved towards limiting local procurement and strengthening a centralised purchasing mechanism through the CPA.
Under the arrangement, hospitals reportedly had less autonomy in purchasing medicines and medical equipment locally, with procurement responsibilities being shifted towards the central agency.
The report further states that the responsibility for procurement was assigned to senior officials of the Directorate General of Health Services and the CPA.
Transparency and Accountability at the Centre of the Issue
The central question arising from the controversy is whether complete documentation exists for the reported Rs. 650-crore procurement.
In any government procurement process, records relating to tenders, purchase orders, invoices, quality tests, stock entries and payments are crucial for establishing transparency and accountability.
If such documents are genuinely unavailable, verifying the actual quantity purchased, supplies received, quality testing conducted and payments made could become difficult. Conversely, if the records exist, producing them before the appropriate authorities could help address the concerns being raised.
